UDX SARS-CoV-2 Molecular Assay
Ultimate Dx's UDX SARS-CoV-2 Molecular Assay is designed to detect SARS-CoV-2 ORF1ab RNA in upper respiratory specimens such as nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs. It is performed using Thermo Fisher Scientific's KingFisher Flex Purification System for RNA extraction and Thermo Fisher's Applied Biosystems QuantStudio 12K platform System for reverse transcription, PCR amplification, and detection. Testing is limited to the Ultimate Dx Laboratory, which is a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, certified high complexity laboratory.
Availability: Commercially Available
| Manufacturer |
| Ultimate Dx Laboratory |
| Product Name |
| UDX SARS-CoV-2 Molecular Assay |
| Detection Category |
| Biological |
| Detection Principle |
| Molecular; |
| Detection Method |
| Assays;Nucleic Acid Amplification; |
| Application |
| Diagnostics; |
| Equipment Type |
| Diagnostic |
| Product Synopsis |
| Ultimate Dx's UDX SARS-CoV-2 Molecular Assay is designed to detect SARS-CoV-2 ORF1ab RNA in upper respiratory specimens such as nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs. It is performed using Thermo Fisher Scientific's KingFisher Flex Purification System for RNA extraction and Thermo Fisher's Applied Biosystems QuantStudio 12K platform System for reverse transcription, PCR amplification, and detection. Testing is limited to the Ultimate Dx Laboratory, which is a Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, certified high complexity laboratory. |
| Availability |
| Commercially Available |
| Technology Readiness Level (TRL) |
| 9 |
| Market Entry Date |
| April 2020 |
| User Feedback Sources |
| Indifferent/No user feedback |
| No Information Is Available |
| Transportability |
| Pocket Size |
| Data Analysis Support Equipment |
| Thermo Fisher Scientific's KingFisher Flex Purification System for RNA extraction and Thermo Fisher's Applied Biosystems QuantStudio 12K platform System for reverse transcription, PCR amplification, and detection |
| Other Biological Targets |
| SARS-CoV-2 |
| Sample Introduction |
| Liquid; Biological sample; nasal swabs, nasopharyngeal swabs, and oropharyngeal swabs |
| Training Required |
| <1 day training |
